Last reviewed 2026-04-23 · How we verify

Systemic Doxycycline and Sham aPDT

Doxycycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis and possesses anti-inflammatory properties; when combined with sham aPDT (antimicrobial photodynamic therapy), it is being evaluated for its potential antimicrobial and immunomodulatory effects.

Doxycycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis and possesses anti-inflammatory properties; when combined with sham aPDT (antimicrobial photodynamic therapy), it is being evaluated for its potential antimicrobial and immunomodulatory effects. Used for Periodontal disease (likely indication based on aPDT context).

At a glance

Mechanism of action

Doxycycline works by binding to bacterial ribosomes and inhibiting protein synthesis, while also exhibiting anti-inflammatory effects through inhibition of matrix metalloproteinases and modulation of immune responses. In this trial, it is being tested alongside sham aPDT (a control photodynamic therapy procedure) to evaluate its efficacy in treating periodontal or oral infections. The combination approach may leverage doxycycline's antimicrobial and anti-inflammatory properties in a clinical setting.

Approved indications

• Periodontal disease (likely indication based on aPDT context)

Common side effects

• Photosensitivity
• Gastrointestinal upset
• Esophageal irritation
• Vaginal yeast infection

Key clinical trials

• Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.